Lasheaka McClellan,
Assistant Director Of Hepatology Clinical Research
Department:
MD-GASTROENTERLOGY-LIVER
Business Phone:
(352) 273-7285
Business Email:
lasheaka.mcclellan@medicine.ufl.edu
Grants
Aug 2024
ACTIVE
Prospective Observational Study on the Natural History of Alpha-1 Antitrypsin Deficiency Associated Liver Disease
Role: Other
Funding: OUTCOME SCIENCES
via TAKEDA DEVELOPMENT CENTER AMERICAS INC
May 2024
ACTIVE
Kowa K-808-2.01 A Phase 2, Randomized, Placebo-controlled,Parallel Group, Multi center 12-week Study with a 52-week Extensionto Evaluate Effi cacy and Safety of Two Doses of K-808 (Pemafi brate)in Subjects with Primary Biliary Cholangiti s with Inadequate Responseto Ursodeoxycholic Acid and/or Obeti cholic Acid Treatment
Role: Other
Funding: PHARMACEUTICAL RES ASSO
via KOWA RESEARCH INSTITUTE
Feb 2024
ACTIVE
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Efruxifermin in Subjects with Non-Invasively Diagnosed Nonalcoholic Steatohepatitis (NASH)/Nonalcoholic Fatty Liver Disease (NAFLD)
Role: Other
Funding: SC LIVER RESEARCH CONSORTIUM
via AKERO THERAPEUTICS
Jan 2024
ACTIVE
D419CR00035 LIVER-R An Observational Mult-Center Study to Evaluate Real-World Treatment Outcomes of Durvalumab-based Regimens in Hepatobiliary Cancers
Role: Other
Funding: ICON CLINICAL RESEARCH INC
via ASTRAZENECA
Dec 2023
ACTIVE
Akero AK-US-001-0105 A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Efruxifermin in Subjects with Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH) and Fibrosis
Role: Other
Funding: SC LIVER RESEARCH CONSORTIUM
via AKERO THERAPEUTICS
Contact Details
Phones:
- Business:
- (352) 273-7285
Emails:
- Business:
- lasheaka.mcclellan@medicine.ufl.edu
Addresses:
- Business Mailing:
-
PO Box 100272
GAINESVILLE FL 32610 - Business Street:
-
Room 2258
2004 Mowry Road
GAINESVILLE FL 32610